These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 20947788)

  • 1. Abandoning peracetic acid-based dialyzer reuse is associated with improved survival.
    Lacson E; Wang W; Mooney A; Ofsthun N; Lazarus JM; Hakim RM
    Clin J Am Soc Nephrol; 2011 Feb; 6(2):297-302. PubMed ID: 20947788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dialyzer reuse with peracetic acid does not impact patient mortality.
    Bond TC; Nissenson AR; Krishnan M; Wilson SM; Mayne T
    Clin J Am Soc Nephrol; 2011 Jun; 6(6):1368-74. PubMed ID: 21566107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of dialyzer reuse on survival of patients treated with hemodialysis.
    Feldman HI; Kinosian M; Bilker WB; Simmons C; Holmes JH; Pauly MV; Escarce JJ
    JAMA; 1996 Aug; 276(8):620-5. PubMed ID: 8773634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of bleach cleaning on the performance of dialyzers with polysulfone membranes processed for reuse using peracetic Acid.
    Ward RA; Ouseph R
    Artif Organs; 2003 Nov; 27(11):1029-34. PubMed ID: 14616521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the association of dialyzer reuse practices and patient outcomes.
    Held PJ; Wolfe RA; Gaylin DS; Port FK; Levin NW; Turenne MN
    Am J Kidney Dis; 1994 May; 23(5):692-708. PubMed ID: 8172212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory response of a new synthetic dialyzer membrane. A randomised cross-over comparison between polysulfone and helixone.
    Stefoni S; Colì L; Cianciolo G; Donati G; Ruggeri G; Ramazzotti E; Pohlmeier R; Lang D
    Int J Artif Organs; 2003 Jan; 26(1):26-32. PubMed ID: 12602466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dialyzer reprocessing with peroxyacetic acid as sole cleansing and sterilizing agent.
    Kes P; Reiner Z; Ratković-Gusić I
    Acta Med Croatica; 1997; 51(2):87-93. PubMed ID: 9204593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and microbiological effects of dialyzers reuse in hemodialysis patients.
    Ribeiro IC; Roza NAV; Duarte DA; Guadagnini D; Elias RM; Oliveira RB
    J Bras Nefrol; 2019; 41(3):384-392. PubMed ID: 30720850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. National Kidney Foundation report on dialyzer reuse. Task Force on Reuse of Dialyzers, Council on Dialysis, National Kidney Foundation.
    Am J Kidney Dis; 1997 Dec; 30(6):859-71. PubMed ID: 9398135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FMCNA says data shows higher risk of mortality among patients on reuse. Industry questions bias in reporting.
    Neumann ME
    Nephrol News Issues; 2004 Oct; 18(11):91. PubMed ID: 15551620
    [No Abstract]   [Full Text] [Related]  

  • 11. Mortality risk by hemodialyzer reuse practice and dialyzer membrane characteristics: results from the usrds dialysis morbidity and mortality study.
    Port FK; Wolfe RA; Hulbert-Shearon TE; Daugirdas JT; Agodoa LY; Jones C; Orzol SM; Held PJ
    Am J Kidney Dis; 2001 Feb; 37(2):276-86. PubMed ID: 11157367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dialyzer reuse-Part I: Historical perspective.
    Twardowski ZJ
    Semin Dial; 2006; 19(1):41-53. PubMed ID: 16423181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of dialyzer reuse on dialysis delivery.
    Sherman RA; Cody RP; Rogers ME; Solanchick JC
    Am J Kidney Dis; 1994 Dec; 24(6):924-6. PubMed ID: 7985670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dialyzer reuse--part II: advantages and disadvantages.
    Twardowski ZJ
    Semin Dial; 2006; 19(3):217-26. PubMed ID: 16689973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maintaining blood compartment volume in dialyzers reprocessed with peracetic acid maintains Kt/V but not beta2-microglobulin removal.
    Ouseph R; Smith BP; Ward RA
    Am J Kidney Dis; 1997 Oct; 30(4):501-6. PubMed ID: 9328364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of dialyzer reuse on the permeability of low-flux membranes.
    Matos JP; André MB; Rembold SM; Caldeira FE; Lugon JR
    Am J Kidney Dis; 2000 May; 35(5):839-44. PubMed ID: 10793017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A quality and cost-benefit analysis of dialyzer reuse in hemodialysis patients.
    Chuang FR; Lee CH; Chang HW; Lee CN; Chen TC; Chuang CH; Chiou TT; Wu CH; Yang CC; Wang IK
    Ren Fail; 2008; 30(5):521-6. PubMed ID: 18569933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-reactive protein and prediction of 1-year mortality in prevalent hemodialysis patients.
    Bazeley J; Bieber B; Li Y; Morgenstern H; de Sequera P; Combe C; Yamamoto H; Gallagher M; Port FK; Robinson BM
    Clin J Am Soc Nephrol; 2011 Oct; 6(10):2452-61. PubMed ID: 21868617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biocompatibility and permeability of dialyzer membranes do not affect anemia, erythropoietin dosage or mortality in japanese patients on chronic non-reuse hemodialysis: a prospective cohort study from the J-DOPPS II study.
    Yokoyama H; Kawaguchi T; Wada T; Takahashi Y; Higashi T; Yamazaki S; Fukuhara S; Akiba T; Akizawa T; Asano Y; Kurokawa K; Saito A;
    Nephron Clin Pract; 2008; 109(2):c100-8. PubMed ID: 18596379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of membrane permeability on inflammation and arterial stiffness: a randomized trial.
    Li PK; Cheng YL; Leung CB; Szeto CC; Chow KM; Kwan BC; Ng ES; Fok QW; Poon YL; Yu AW
    Clin J Am Soc Nephrol; 2010 Apr; 5(4):652-8. PubMed ID: 20203165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.